Septerna

About:

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

Website: https://septerna.com

Twitter/X: Septerna_Inc

Top Investors: RA Capital Management, Invus, Samsara BioCapital, Biotechnology Value Fund, Catalio Capital Management

Description:

Septerna is a biotechnology company that discovers and advances novel small-molecule medicines targeting G protein-coupled receptors. The company's mission is to discover, develop, and commercialize medicines that improve the lives of patients by combining GPCR drug targets with the power of state-of-the-art small molecule drug discovery technologies. Septerna’s Native Complex platform is the engine that will make this happen.